Direct AAV-mediated gene delivery to the temporomandibular joint

被引:11
|
作者
Dai, Juan [1 ]
Bakr, A. [1 ]
Rabie, M. [1 ]
机构
[1] Univ Hong Kong, Fac Dent, Biomed & Tissue Engn Grp, Hong Kong, Hong Kong, Peoples R China
来源
关键词
gene therapy; adeno-associated virus; enhanced green fluorescence protein; PCR; mandibular condyle;
D O I
10.2741/2224
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful intra-temporomandibular joint gene transfer is a prerequisite for gene therapy to induce mandibular condylar growth. This study was carried out to investigate the expression of recombinant adeno-associated virus ( rAAV) based vector-mediated enhanced green fluorescence protein ( eGFP) in the mandibular condyle. The transduction efficiencies for primary chondrocytes using different hybrids of rAAV vectors were identified by fluorescence microscopy and FACS. Sprague-Dawley rats were injected with either rAAV(2/2)-eGFP construct or saline into both mandibular condyles. The spatial and temporal transgene expression was detected by in situ hybridization, RT-PCR and real-time PCR. Our result showed that rAAVs were capable of infecting rat chondrocytes. rAAV(2/2) was the best serotype to infect chondrocytes in vitro. By in situ hybridization, eGFP expression was clearly detected in the deeper layer of mandibular condyle as early as 7 days after injection. By real-time PCR, the transgene expression reached a peak at 21 days. This study was the first report to explore that rAAV-mediated genes could be transferred to mandibular condyle in vivo. Our results strongly suggest that rAAV(2/2) mediated gene delivery is a promising approach to deliver candidate genes for future regulating mandibular condylar growth.
引用
收藏
页码:2212 / 2220
页数:9
相关论文
共 50 条
  • [31] AAV-mediated gene therapy of Pompe disease
    Ziegler, RJ
    Bercury, S
    Armentaro, D
    Raben, N
    Cheng, SH
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 713 - 713
  • [32] AAV-mediated gene transfer for retinal diseases
    Allocca, Mariacarmela
    Tessitore, Alessandra
    Cotugno, Gabriella
    Auricchio, Alberto
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (12) : 1279 - 1294
  • [33] Immunology of AAV-mediated gene transfer in the eye
    Willett, Keiman
    Bennett, Jean
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [34] THE EFFECTS OF SEROTYPES AND ROUTE OF ADMINISTRATION ON TRANSDUCTION EFFICIENCY FOR AAV-MEDIATED GENE DELIVERY TO THE CNS
    Tamrazian, E.
    Benn, S.
    O'Riordan, C.
    Brown, R. H., Jr.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (03): : 72 - 81
  • [35] SUSTAINED HIGH LEVEL EXPRESSION OF FVII FOLLOWING AAV-MEDIATED GENE DELIVERY IN VIVO
    D'Amico, A.
    Blits, B.
    Van Den Herik, J.
    De Winter, F.
    Kaijen, P.
    Hobo, B.
    Verhaagen, J.
    Mosmuller, D.
    Voorberg, J.
    HAEMOPHILIA, 2023, 29 : 13 - 14
  • [36] Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina
    Sanftner, LHM
    Rendahl, KG
    Quiroz, D
    Coyne, M
    Ladner, M
    Manning, WC
    Flannery, JG
    MOLECULAR THERAPY, 2001, 3 (05) : 688 - 696
  • [37] Optimization of AAV-mediated Gene Delivery for Targeting Mitochondria in the Outer Retina and Muller glia
    Zin, Emilia Araujo
    Fortuny, Cecile
    Sabetfakhri, Niki P.
    Choi, Rachel J.
    Dunlap, Carolyn
    Flannery, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] AAV-mediated gene therapies by miniature gene editing tools
    Kong, Xiangfeng
    Li, Tong
    Yang, Hui
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (12) : 2540 - 2553
  • [39] AAV-mediated gene therapies by miniature gene editing tools
    Xiangfeng Kong
    Tong Li
    Hui Yang
    Science China(Life Sciences), 2024, 67 (12) : 2540 - 2553
  • [40] AAV-mediated gene targeting methods for human cells
    Khan, Iram F.
    Hirata, Roli K.
    Russell, David W.
    NATURE PROTOCOLS, 2011, 6 (04) : 482 - 501